Vertex Pharmaceuticals, Inc. (VRTX)
515.44
+0.88
(+0.17%)
USD |
NASDAQ |
Sep 11, 16:00
515.73
+0.29
(+0.06%)
After-Hours: 20:00
Vertex Pharmaceuticals Total Return Level : 515.44 for Sept. 11, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 11, 2026 | 515.44 |
| September 10, 2026 | 514.56 |
| September 09, 2026 | 521.12 |
| September 08, 2026 | 528.90 |
| September 04, 2026 | 546.12 |
| September 03, 2026 | 557.96 |
| September 02, 2026 | 556.75 |
| September 01, 2026 | 547.65 |
| August 31, 2026 | 544.52 |
| August 28, 2026 | 541.69 |
| August 27, 2026 | 547.55 |
| August 26, 2026 | 547.29 |
| August 25, 2026 | 552.85 |
| August 24, 2026 | 547.59 |
| August 21, 2026 | 548.05 |
| August 20, 2026 | 540.26 |
| August 19, 2026 | 552.06 |
| August 18, 2026 | 528.19 |
| August 17, 2026 | 515.55 |
| August 14, 2026 | 505.75 |
| August 13, 2026 | 516.44 |
| August 12, 2026 | 525.73 |
| August 11, 2026 | 529.65 |
| August 10, 2026 | 523.91 |
| August 07, 2026 | 496.07 |
| Date | Value |
|---|---|
| August 06, 2026 | 484.03 |
| August 05, 2026 | 484.83 |
| August 04, 2026 | 478.70 |
| August 03, 2026 | 470.72 |
| July 31, 2026 | 477.10 |
| July 30, 2026 | 481.70 |
| July 29, 2026 | 483.33 |
| July 28, 2026 | 490.39 |
| July 27, 2026 | 479.00 |
| July 24, 2026 | 477.36 |
| July 23, 2026 | 473.09 |
| July 22, 2026 | 472.57 |
| July 21, 2026 | 482.00 |
| July 20, 2026 | 480.50 |
| July 17, 2026 | 485.65 |
| July 16, 2026 | 486.03 |
| July 15, 2026 | 477.08 |
| July 14, 2026 | 476.31 |
| July 13, 2026 | 480.25 |
| July 10, 2026 | 485.39 |
| July 09, 2026 | 496.50 |
| July 08, 2026 | 498.43 |
| July 07, 2026 | 522.25 |
| July 06, 2026 | 529.59 |
| July 02, 2026 | 528.04 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Gilead Sciences, Inc. | 209.46 |
| Alnylam Pharmaceuticals, Inc. | 248.68 |
| Sionna Therapeutics, Inc. | 7.85 |
| Regeneron Pharmaceuticals, Inc. | 788.74 |
| Biogen, Inc. | 217.15 |